| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 12 | |
| #2 | China | 6 | |
| #3 | Norway | 6 | |
| #4 | United States | 6 | |
| #5 | Australia | 5 | |
| #6 | Hong Kong | 5 | |
| #7 | Japan | 5 | |
| #8 | Canada | 4 | |
| #9 | Republic of Korea | 3 | |
| #10 | Mexico | 3 | |
| #11 | WIPO (World Intellectual Property Organization) | 2 | |
| #12 | South Africa | 2 | |
| #13 | Brazil | 1 | |
| #14 | EAPO (Eurasian Patent Organization) | 1 | |
| #15 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Andersen Mads Hald | 57 |
| #2 | Straten Eivind Per Thor | 35 |
| #3 | Straten Per Thor | 5 |
| #4 | Hald Andersen Mads | 4 |
| #5 | Thor Straten Eivind Per | 3 |
| #6 | Mads Hald Andersen | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2011203536A1 | Survivin peptide vaccine | |
| AU2011203535A1 | Survivin peptide vaccine | |
| CN101111260A | Survivin peptide vaccine | |
| ZA200604866B | Proteins belonging to the BCL-2 family and fragments thereof, and their use in cancer patients | |
| US2007036811A1 | Therapeutic cancer vaccine | |
| AU2004228106A1 | Therapeutic cancer vaccine | |
| CN103288920A | Survivin-derived peptide and use thereof | |
| US2004176573A1 | Survivin-derived peptides and use thereof |